-
Product Insights
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Diabetic Retinopathy Drugs Market Report Overview Diabetic retinopathy is a complication of diabetes that affects the eyes. The symptoms may include spots or dark strings floating in vision (floaters), blurred vision, fluctuating vision, vision loss, and difficulty with color perception. The Diabetic Retinopathy pipeline drugs market research report provides comprehensive information on the therapeutics under development for Diabetic Retinopathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Type 1 Diabetes Pipeline Drugs Market Report Overview Type 1 diabetes (T1D) occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas. The signs and symptoms of type 1 diabetes include increased thirst and frequent urination, extreme hunger, weight loss, fatigue, and irritability or unusual behavior. The Type 1 Diabetes pipeline drugs market research report provides comprehensive information on the therapeutics under development for Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders), complete with analysis by...
-
Product Insights
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Type 2 diabetes is the most common form of diabetes. The symptoms include fatigue, weight issues, vision deficits, and various other effects. Risk factors include family history, age, obesity, physical inactivity, and high blood pressure. The Type 2 Diabetes pipeline drugs market research report provides comprehensive information on the therapeutics under development for Type 2 Diabetes (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report...
-
Product Insights
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Hypercholesterolemia pipeline drugs market research report provides comprehensive information on the therapeutics under development for Hypercholesterolemia (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews key players involved in therapeutic development for Hypercholesterolemia and features dormant and discontinued...
-
Product Insights
Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Heterozygous familial hypercholesterolemia (heFH) pipeline drugs market research report provides comprehensive information on the therapeutics under development for Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews key players involved in therapeutic development for...
-
Product Insights
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Obesity Pipeline Drugs Market Overview Obesity is defined as having an excessive amount of body fat. Obesity increases the risk of diseases and health problems such as heart disease, diabetes, and high blood pressure. The predisposing factors include age, family history, smoking, lack of sleep, and certain medications. The obesity pipeline drugs market research report provides comprehensive information on the therapeutics under development for obesity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
-
Sector Analysis
EpiCast Report: Dyslipidemia – Epidemiology Forecast to 2025
Dyslipidemia is a condition in which one or more of the serum lipid levels are abnormal. It is a well-established risk factor for cardiovascular disease (CVD), and the burden of morbidity, mortality, and medical costs arising from dyslipidemia is substantial The clinical diagnostic criteria for dyslipidemia and serum lipid abnormalities vary across countries and depend on the disease treatment and management guidelines that are followed in each country. Guidelines for the detection, evaluation, treatment, and management of dyslipidemia, as well...
-
Product Insights
Tay-Sachs Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Tay-Sachs Disease Global Clinical Trials Review, H2, 2016" provides an overview of Tay-Sachs Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Tay-Sachs Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016" provides an overview of Becker Muscular Dystrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Becker Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016" provides an overview of Glycogen Storage Disorders (GSD) clinical trials scenario. This report provides top line data relating to the clinical trials on Glycogen Storage Disorders (GSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.